Trainline Upgrades FullYear Guidance for Second Time This Year GLSI Q3 2025 Earnings NarrowerthanExpected Loss as Biotech Advances Clinical Pipeline Mercurys 52 Billion Valuation Marks Continued Fintech Resilience